China NMPA Drug Inspection - Chongqing Kerui Pharmaceutical (Group) Co., Ltd. - Chenxianglu Bailu Pian
China NMPA drug inspection for Chongqing Kerui Pharmaceutical (Group) Co., Ltd. published October 08, 2021. Drug: Chenxianglu Bailu Pian. In an announcement dated October 8, 2021, the Sichuan Provincial Drug Administration identified quality failures in thre
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Chongqing Kerui Pharmaceutical (Group) Co., Ltd. published October 08, 2021. Drug: Chenxianglu Bailu Pian. In an announcement dated October 8, 2021, the Sichuan Provincial Drug Administration identified quality failures in thre
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox